Richard Wahl

16PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDeep learningCancer diagnosisAccelerators
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 26, 2026
Reply to Çınar, A. The Potential Role of Organ-to-Liver Ratios in Immune-Related FDG PET Imaging. Comment on "Panikar et al. Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis. Int. J. Mol. Sci. 2026, 27, 5129".

|Jun 12, 2026
Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis.

|Apr 03, 2025
Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response.

Maeve A Hennessy, Ashley Cimino-Mathews, Jodi M Carter

|May 11, 2024
Patlak Slope versus Standardized Uptake Value Image Quality in an Oncologic PET/CT Population: A Prospective Cross-Sectional Study.

Semra Ince, Richard Laforest, Malak Itani

|Apr 10, 2024
A Semiautonomous Deep Learning System to Reduce False Positives in Screening Mammography.

Stefano Pedemonte, Trevor Tsue, Brent Mombourquette

|Aug 04, 2023
Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations.

Marilyn J Siegel, Joseph E Ippolito, Richard L Wahl

Pageof 3

Frequent Collaborators

4 joint publications

Daniel Lj Thorek

3 joint publications

Joseph E Ippolito

2 joint publications

Mothaffar Rimawi

2 joint publications

Ian E Krop